1976
DOI: 10.1210/jcem-42-3-603
|View full text |Cite
|
Sign up to set email alerts
|

Effect of Pyridoxine on Human Hypophyseal Trophic Hormone Release: A Possible Stimulation of Hypothalamic Dopaminergic Pathway.

Abstract: A single dose of pyridoxine (300 mg iv) produced significant rises in peak levels of immunoreactive growth hormone GH and significant decrease of plasma prolactin PRL in 8 hospitalized healthy subjects. Serum glucose, luteinizing hormone LH, follicle stimulating hormone FSH and thyrotropin TSH were not altered significantly. In addition, in 5 acromegalic patients who were studied with both L-dopa and pyridoxine, inhibition of GH secretion followed either agent in a similar pattern. These data suggest a hypotha… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
7
0
2

Year Published

1979
1979
2017
2017

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 49 publications
(10 citation statements)
references
References 0 publications
1
7
0
2
Order By: Relevance
“…However, androstenedione works antagonistically with estrogen and PRL if these are elevated then testosterone levels decrease. PRL inhibits the release of gonadotropin-releasing hormone (GnRH) which is released from the hypothalamus (Delitala, 2009), some studies suggest that testosterone regulates the secretion of prolactin through a long feedback mechanism (Gill-Sharma, 2008). Estrogens are known to stimulate growth of pituitary and also to promote PRL release resulting in elevated PRL levels systemically (Perez et al, 1986).…”
Section: Discussionmentioning
confidence: 99%
“…However, androstenedione works antagonistically with estrogen and PRL if these are elevated then testosterone levels decrease. PRL inhibits the release of gonadotropin-releasing hormone (GnRH) which is released from the hypothalamus (Delitala, 2009), some studies suggest that testosterone regulates the secretion of prolactin through a long feedback mechanism (Gill-Sharma, 2008). Estrogens are known to stimulate growth of pituitary and also to promote PRL release resulting in elevated PRL levels systemically (Perez et al, 1986).…”
Section: Discussionmentioning
confidence: 99%
“…Reports on effects of PLP on PRL and GH secretion in vivo have been contradictory (13)(14)(15)(16)(17)(18). Vitamin B6 may act on neural function in vivo through its involvement as a cofactor for dopamine.…”
Section: Discussionmentioning
confidence: 99%
“…Administration of vitamin B6 (either 300 mg acute infusion or 400-600 mg orally daily for 2-3 months) to human volunteers (13)(14)(15)(16) reduced circulating PRL levels (13,14,16), but PLPinduced GH reduction was only observed in acromegaly (14) and in infants (15). Vitamin B6induced hormone suppression was not reproduced in other in vivo studies (17,18).…”
Section: Introductionmentioning
confidence: 99%
“…The therapeutic use o f these compounds will be presented in the part of this review concerned with clinical aspects o f lactogenic hormones. Pyridoxine (vitamin B6), acting as a coenzyme to stimulate the synthesis of DA, has been claimed to suppress PRL secretion (156,157), but these findings have not been confirmed (158 161). Among these sympathicomimetic compounds, amphetamine has been found to moderately elevate basal PRL and augment spiking in one case studied (150).…”
Section: Drugs In Clinical Use Modifying the Secretion Of Pr Lmentioning
confidence: 99%